SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-207627
Filing Date
2013-05-08
Accepted
2013-05-08 16:35:16
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d506842d10q.htm 10-Q 466039
2 EX-31.1 d506842dex311.htm EX-31.1 9216
3 EX-31.2 d506842dex312.htm EX-31.2 9195
4 EX-32.1 d506842dex321.htm EX-32.1 4121
5 EX-32.2 d506842dex322.htm EX-32.2 4025
  Complete submission text file 0001193125-13-207627.txt   2440118

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cort-20130331.xml EX-101.INS 234211
7 XBRL TAXONOMY EXTENSION SCHEMA cort-20130331.xsd EX-101.SCH 22820
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cort-20130331_cal.xml EX-101.CAL 37536
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cort-20130331_def.xml EX-101.DEF 139519
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20130331_lab.xml EX-101.LAB 192899
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20130331_pre.xml EX-101.PRE 162347
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 13825017
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1